Eugia lidocaine HCl injection recalled for barcode labeling issue
The label wrap on Eugia US LLC lidocaine HCl Injection, USP 2%, 40 mg/2 mL single-dose vials covers the barcode, making it hard to scan. The recall covers 168,300 vials in two lots distributed nationwide. No injuries have been reported.
From the FDA notice · Read the official notice ↗
What to do
- Set aside vials from lots 3LC26029A (exp Feb-2029) and 3LC26031A (exp Mar-2029) with NDC 55150-164-02.
- Contact Eugia US LLC for next steps. The notice doesn't say how to get a return or replacement.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
Details
- Units affected
- 168,300 vials
- Illnesses reported
- None reported
- Manufactured in
- 279 Princeton Hightstown Rd, East Windsor, NJ, United States
- Classification
- Class III
- Recall number
- D-0552-2026
In the FDA's words
- Description
- Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02 Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029 Distribution: US Nationwide. Affected quantity: 168,300 vials
- Hazard
- Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan